Compounds Which Modulate The CB2 Receptor

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors ERMANN MONIKA, JENKINS JAMES EDWARD, BERRY ANGELA, PALMER CHRISTOPHER FRANCIS, CHOWDHURY CHANDANA, MUSHI INNOCENT, RIETHER DORIS, CIRILLO PIER FRANCESCO, THOMSON DAVID, ZINDELL RENEE M, BLUMIRE NIGEL, HICKEY EUGENE RICHARD, TAYLOR MALCOLM
Format Patent
LanguageEnglish
Published 02.06.2011
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
AbstractList Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Author BERRY ANGELA
HICKEY EUGENE RICHARD
ZINDELL RENEE M
BLUMIRE NIGEL
JENKINS JAMES EDWARD
RIETHER DORIS
MUSHI INNOCENT
TAYLOR MALCOLM
CHOWDHURY CHANDANA
CIRILLO PIER FRANCESCO
PALMER CHRISTOPHER FRANCIS
ERMANN MONIKA
THOMSON DAVID
Author_xml – fullname: ERMANN MONIKA
– fullname: JENKINS JAMES EDWARD
– fullname: BERRY ANGELA
– fullname: PALMER CHRISTOPHER FRANCIS
– fullname: CHOWDHURY CHANDANA
– fullname: MUSHI INNOCENT
– fullname: RIETHER DORIS
– fullname: CIRILLO PIER FRANCESCO
– fullname: THOMSON DAVID
– fullname: ZINDELL RENEE M
– fullname: BLUMIRE NIGEL
– fullname: HICKEY EUGENE RICHARD
– fullname: TAYLOR MALCOLM
BookMark eNrjYmDJy89L5WTQdM7PLcgvzUspVgjPyEzOUPDNTynNSSxJVQjJSFVwdjJSCEpNTi0oyS_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoaGhsYGJsaGjobGxKkCAC0eKkQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2011130431A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2011130431A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2011130431A13
Notes Application Number: US201113022866
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110602&DB=EPODOC&CC=US&NR=2011130431A1
ParticipantIDs epo_espacenet_US2011130431A1
PublicationCentury 2000
PublicationDate 20110602
PublicationDateYYYYMMDD 2011-06-02
PublicationDate_xml – month: 06
  year: 2011
  text: 20110602
  day: 02
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies BOEHRINGER INGELHEIM INTERNATIONAL GMBH
RelatedCompanies_xml – name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Score 2.8089676
Snippet Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Compounds Which Modulate The CB2 Receptor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110602&DB=EPODOC&locale=&CC=US&NR=2011130431A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIJS8KEY-rXuoYhNW4bQbbhV9zaaNGUD2Yqt-O97iavuaW9HApcvfrmPXO4A7vtu5lm2xQzOcjRQOFIecYTBeyYnZs4Iy6UfMhm6g9R-mTmzFnw0f2FUntBvlRwREcUR77W6r8t_J1aoYiurR7bEpvVTPPVDPW_cfcQlph4GfjQehSOqU-qnE334qvrwukZx-Yy20h4q0j2Jh-gtkP9Sym2hEh_D_hj5reoTaIlVBw5pU3utAwfJ5skbyQ36qlN4kOCVZZAq7X2x5AstWeey-pbQ8LA1GpgaKoGiRCv6DO7iaEoHBo45_1viPJ1sT9A6hzYa_-ICNFIUlkwRJ0Ob7KJHmKyV0Xe8rPCyTNjZJXR3cbra3X0NR78-UhmI3IV2_fklblDI1uxW7c0P0jp-DQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakAJeAguSZqmhyDmRdQmLTbR3ko22dCCtMFG_PvOro321NuwC7Mvvp3Hzs4A3PaN1NR0jSoZzdFAyZAySZcpWU_NiJpTQnPuhwwjI0j050l30oCP-i-MyBP6LZIjIqIyxHsl7uvy34nlitjK1T2dY9PywY8tV85rdx8xiCq7tuWNhu7QkR3HSsZy9Cr68LpGcfmIttIOKtk9jgfvzeb_UspNoeIfwO4I-S2qQ2iwRRtaTl17rQ174frJG8k1-lZHcMfBy8sgraT32TybSeEy59W3mISHLTm2KqESyEq0oo_hxvdiJ1BwzOnfEqfJeHOC2gk00fhnpyCRotB4ijge2qQXPUJ5rYx-10wLM02Znp5BZxun8-3d19AK4nAwHTxFLxew_-sv5UHJHWhWn1_sEgVuRa_EPv0A5uqBAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compounds+Which+Modulate+The+CB2+Receptor&rft.inventor=ERMANN+MONIKA&rft.inventor=JENKINS+JAMES+EDWARD&rft.inventor=BERRY+ANGELA&rft.inventor=PALMER+CHRISTOPHER+FRANCIS&rft.inventor=CHOWDHURY+CHANDANA&rft.inventor=MUSHI+INNOCENT&rft.inventor=RIETHER+DORIS&rft.inventor=CIRILLO+PIER+FRANCESCO&rft.inventor=THOMSON+DAVID&rft.inventor=ZINDELL+RENEE+M&rft.inventor=BLUMIRE+NIGEL&rft.inventor=HICKEY+EUGENE+RICHARD&rft.inventor=TAYLOR+MALCOLM&rft.date=2011-06-02&rft.externalDBID=A1&rft.externalDocID=US2011130431A1